Solvay Pharma India Ltd.[Amalgamated] - Research Center
532447 DUPHARPH Group (N.A.) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Dec ' 10 |
Jun ' 10 |
Dec ' 09 |
Jun ' 09 |
Dec ' 08 |
Sales |
160.22 |
136.69 |
130.80 |
115.71 |
103.55 |
Operating profit |
35.24 |
40.13 |
32.77 |
28.86 |
24.90 |
Interest |
- |
- |
- |
- |
0.01 |
Gross profit |
37.37 |
41.68 |
34.27 |
29.70 |
26.28 |
EPS (Rs) |
47.81 |
52.89 |
43.02 |
36.25 |
32.86 |
Half yearly
results in details
|
Dec ' 10 |
Jun ' 10 |
Dec ' 09 |
Jun ' 09 |
Dec ' 08 |
Other income |
2.13 |
1.55 |
1.50 |
0.84 |
1.39 |
Stock adjustment |
5.08 |
-4.35 |
0.91 |
1.29 |
-6.55 |
Raw material |
25.76 |
28.71 |
27.06 |
22.73 |
25.39 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
19.26 |
14.47 |
14.20 |
12.27 |
10.74 |
Excise |
- |
- |
- |
3.36 |
-7.14 |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
74.88 |
57.74 |
55.86 |
47.21 |
56.20 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
1.62 |
1.58 |
2.06 |
1.25 |
0.60 |
Taxation |
11.61 |
13.39 |
10.48 |
10.15 |
9.08 |
Net profit / loss |
24.14 |
26.71 |
21.73 |
18.30 |
16.59 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
5.05 |
5.05 |
5.05 |
5.05 |
5.05 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
5.63 |
5.63 |
15.73 |
15.73 |
15.73 |
Agg.of non promotoholding (%) |
11.15 |
11.15 |
31.15 |
31.15 |
31.15 |
OPM (%) |
21.99 |
29.36 |
25.06 |
24.94 |
24.05 |
GPM (%) |
23.02 |
30.15 |
25.90 |
25.48 |
25.04 |
NPM (%) |
14.87 |
19.32 |
16.42 |
15.70 |
15.81 |